For diagnostic labs & health-services partners

Turn raw sequencing into a clinical product line.

CellWise is the turn-key translation layer between a single-cell run and a report a clinician can act on. License it, co-brand it, or white-label it into the menu of services you already sell.

✓ Modular engine licensing ✓ Co-brand or white-label ✓ API integration
Your Lab · powered by CellWise
Portal status
Live
CellWise API
Connected
YL
YOUR LAB
powered by CellWise · white-label ready
QC · batch effects
Cleared
Modules licensed
7 / 7
Deployment options
Co-brand, white-label, or API integration into your existing menu of services
Grounded inreal population datapeer-reviewed researchlegacy single-cell technology
Two ways to partner

Whether you run the instruments or own the patient.

CellWise sits between raw single-cell data and the clinician, so both sides of the market can sell it as their own.

Diagnostic labs & CROs

Monetize the sequencing you already run.

You operate the single-cell sequencing instruments. CellWise turns the HDF5 and Seurat objects into structured, clinician-ready reports, so you can layer software margin on top of the assays already moving through your lab.

→ Add a higher-margin software line to an existing test menu
Health-services companies

Add single-cell under your own brand.

You have the patient relationship and a menu of services. CellWise gives you single-cell decision support to sell inside it, co-branded or fully white-labeled, without standing up a computational-biology team of your own.

→ Launch a new service line without building the science
What you'd be licensing

The layer between a sequencer and a decision.

The parts that are hard to build in-house: the translation, the quality control, and the clinical engines on top.

01

Turn-key translation layer

Raw single-cell files in, structured clinician-ready reports out, through a structured API. Your team ships a clinical product without hiring computational biologists to interpret HDF5 or Seurat objects.

→ The build you skip
02

QC that preserves rare signal

Strict filters remove apoptotic cells, and MAD-based normalization against a population baseline eliminates batch effects while keeping the rare functional anomalies that mean/standard-deviation methods erase.

→ Reproducible across runs, clinically defensible
03

Modular engine licensing

License the Peptide Atlas, Cellular Aging Profile, and Clinical Surveillance as individual line items, or the full seven-module workspace. Priced so the software margin sits above the cost of the assay.

→ Take what fits your menu
Licensing models

Pick the integration that fits your brand.

Four ways to bring CellWise to market, from fastest-to-launch to fully your own.

Model 01

Co-brand

Your mark alongside CellWise. The fastest path to market, with shared credibility on every report your patients and clinicians see.

Model 02

White-label

Fully your brand. CellWise powers the science silently while you own the interface, the naming, and the report templates.

Model 03

API integration

Pipe results straight into your existing LIS or patient portal through a structured API, and add single-cell to the menu you already run.

Model 04

Full menu embed

License the engines as catalog line items and sell them inside your current test menu, priced and branded as your own service.

Branding & logoReport templatesTest-menu namingUI themeCustom domainPatient-facing languageEngine selection
Everything in the platform

The seven-module workspace you'd be licensing.

Health Analysis ReportIllustrative preview
SemaglutideGLP-1 receptor agonist · mapped with tirzepatide
Strong match
  1. Cell stateInnate inflammation on, in CD14 monocytes
  2. Genes4 move with the state, 1 against
  3. PathwayNF-κB and IL-1β
  4. MechanismLowered IL-1β and TNF in mononuclear cells in a randomised trial; pooled trials lower CRP. Human data
  5. Check firstA recent infection or vaccine, or hard exercise before the draw
In line with the state
IL1B ↑CXCL8 ↑NLRP3 ↑TNF ↑
Moving against it
CCL2 ↓

Read in this patient's CD14 monocytes against people of the same sex in the reference set.

Mechanism: human dataResponse: CellWise prediction, not yet validated
Module 01

Health Analysis Report

The clinical home base: risk-rated health domains, immuno-metabolic phenotyping, and mechanism-based peptide pairing, each call traced from cell state to genes, pathway and mechanism.

Clinicians see
Each peptide call explained: the cell state, the genes moving with it and against it, the pathway, the evidence tier and what to check first.
Licensees get
Report templates in your brand, under co-brand or white-label.
Biomarker AnalyticsIllustrative preview
S100A12
IL1B
ISG15
CCR7
TCF7
PRF1
HSPA5
same-sex reference rangethis patient
Module 02

Biomarker Analytics

The quantitative, visual view of the patient's raw biomarker data, shown as a population-vs-patient overview.

Clinicians see
Every panel gene placed against the same-sex reference population, the outliers first.
Licensees get
The same views themed to your interface, or piped through the API.
Data ExplorerIllustrative preview
IL1B
Cell populationDirectionSignal
CD14 monocytes↑
CD16 monocytes↑
pDCs↑
CD4 T cells·
Module 03

Data Explorer

A filterable, gene-level interface over the patient's complete dataset, exposing the top cell populations carrying each signal.

Clinicians see
Filter by gene, cell type or direction and see which populations carry each signal.
Licensees get
Gene-level data your scientific team can query, not just a PDF.
Clinical Scenario SimulatorIllustrative preview
HypothesisWhat if this patient starts a GLP-1 receptor agonist?
Re-running against this patient's data
Inflammasome tone
Insulin signalling
Interferon response
Module 04

Clinical Scenario Simulator

Test a clinical hypothesis against the patient's own molecular data and re-run it in seconds.

Clinicians see
Pose a clinical hypothesis against the patient's own data and re-run it in seconds.
Licensees get
A consult tool that keeps clinicians working inside your platform.
Outcomes & MonitoringIllustrative preview
BaselineLoadingMaintenance
Peptide-specific labWearable trend (HRV)
Module 05

Outcomes & Monitoring

Assay-independent surveillance across dosing phases, peptide-specific labs, and wearable trends, with no repeat sequence required.

Clinicians see
Peptide-specific labs and wearable trends tracked across dosing phases, between screens.
Licensees get
A monitoring loop that brings patients back to your menu between draws.
Cellular Aging ProfileIllustrative preview
Immune agewhich compartments are aging fastest, and which hallmarks drive it
Genomic instabilityTelomere attritionEpigenetic alterationProteostasisAutophagyNutrient sensingMitochondriaSenescenceStem-cell exhaustionCommunicationInflammationDysbiosis
Module 06

Cellular Aging Profile

Immune age, senescence, and the 12 hallmarks from one PBMC sample, for cell-resolved biological aging.

Clinicians see
Immune age, senescence and the 12 hallmarks of aging from one PBMC sample.
Licensees get
A preventative-health line item you can list under your own name.
Longitudinal ScreeningIllustrative preview
IL1B · CD14 mono
↓
ISG15 · CD16 mono
·
CCR7 · CD4 T
↑
DDIT3 · NK
↓
Screen 1Screen 2
Module 07

Longitudinal Screening

Re-assay a patient and see the gene-expression deltas across key biomarkers, so you see what has shifted since the last screen.

Clinicians see
Re-assay and see exactly which genes moved, in which cells, since the last screen.
Licensees get
Re-assay built into the product, so the second test is part of the plan.
Hover or tap a module to stop on it. Previews are illustrative.
Built to embed

Engineered for reproducibility and margin.

The technical and commercial reasons a lab can put its own name on the output.

381
Biomarker genes across immune cell populations, the resolution bulk panels average away.
MAD
Median-absolute-deviation normalization against a dynamic population baseline eliminates batch effects run to run.
Rare kept
Apoptotic-cell filtering preserves rare functional anomalies that mean and standard-deviation methods erase.
API
Results pipe into your existing LIS or patient portal, no new systems to run.
7
Licensable modules, taken individually as catalog line items or as the full workspace.
SaMD
A software-as-a-medical-device pathway, research use until clearance, so the regulatory posture is shared and explicit.
From the review room

What partners see in the platform.

“

Transforming HDF5 and Seurat objects into something a referring physician can read used to require a computational-biology team we didn't have. This is the translation layer that lets us monetize the sequencing we already run.

Clinical Pathologist & Lab Director
Beta review
“

The MAD normalization against a population baseline is what makes the output reproducible enough for us to put our own name on it across sample runs.

Diagnostic CRO · Operations
Beta review
“

White-labeling a validated single-cell service into our existing menu is a new revenue line we could never have built the science for on our own.

Health-Services Company · Product
Beta review
◆ Illustrative, not testimonial. These show the kind of read the report supports, drafted from clinician personas during beta design rather than quoted from named practitioners. Reviews from the founding pilot will replace them.

Let's scope a licensing model.

Tell us what you already sell and how you reach patients, and we'll map the fastest path to co-brand, white-label, or integrate CellWise into your menu.